At the end of treatment, liver enzymes including ALT, AST, TB, and ALP were higher in patients with compensated liver cirrhosis than in non-cirrhotic healthy individuals and were statistically significant (p= 0.012, 0.002, 0.048, and 0.015, respectively) (Table 2). The gene discussed is GPT; the disease is cirrhosis of liver.